A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy

• Verfasst von: Langer, Rupert [VerfasserIn]
• Verfasst von: Peters, Leila [VerfasserIn]
• Verfasst von: Büchler, Markus W. [VerfasserIn]
• Verfasst von: Weichert, Wilko [VerfasserIn]
• Verfasst von: Ott, Katja [VerfasserIn]
• Titel: A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy
• Verf.angabe: Rupert Langer, Karen Becker, Inti Zlobec, Ralf Gertler, Leila Sisic, Markus Büchler, Florian Lordick, Julia Slotta-Huspenina, Wilko Weichert, Heinz Höfler, Marcus Feith, and Katja Ott
• Jahr: 2014
• Jahr des Originals: 2013
• Umfang: 7 S.
• Fussnoten: Published: 27 November 2013 ; Gesehen am 12.08.2020
• Titel Quelle: Enthalten in: Annals of surgical oncology
• Ort Quelle: Berlin [u.a.] : Springer, 1994
• Jahr Quelle: 2014
• Band/Heft Quelle: 21(2014), 3, Seite 915-921
• ISSN Quelle: 1534-4681
• DOI: doi:10.1245/s10434-013-3410-y
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1726841790

Abstract

For esophageal adenocarcinoma treated with neoadjuvant chemotherapy, postoperative staging classifications initially developed for non-pretreated tumors may not accurately predict prognosis. We tested whether a multifactorial TNM-based histopathologic prognostic score (PRSC), which additionally applies to tumor regression, may improve estimation of prognosis compared with the current Union for International Cancer Control/American Joint Committee on Cancer (UICC) staging system.